Small interfering RNA-mediated inhibition of hepatitis C virus replication in the human hepatoma cell line Huh-7.
作者信息
Seo Mi Young, Abrignani Sergio, Houghton Michael, Han Jang H
出版信息
J Virol. 2003 Jan;77(1):810-2. doi: 10.1128/jvi.77.1.810-812.2003.
Abstract
摘要
相似文献
1
Small interfering RNA-mediated inhibition of hepatitis C virus replication in the human hepatoma cell line Huh-7.
J Virol. 2003 Jan;77(1):810-2. doi: 10.1128/jvi.77.1.810-812.2003.
2
Transcriptomic comparison of human hepatoma Huh-7 cell clones with different hepatitis C virus replication efficiencies.
Jpn J Infect Dis. 2007 Jul;60(4):173-8.
3
MicroRNA-122-dependent and -independent replication of Hepatitis C Virus in Hep3B human hepatoma cells.
Virology. 2013 Feb 5;436(1):179-90. doi: 10.1016/j.virol.2012.11.007. Epub 2012 Dec 13.
4
Hepatitis B virus and hepatitis C virus interaction in Huh-7 cells.
J Hepatol. 2009 Sep;51(3):446-57. doi: 10.1016/j.jhep.2009.04.025. Epub 2009 Jun 3.
5
Interleukin-32: a new proinflammatory cytokine involved in hepatitis C virus-related liver inflammation and fibrosis.
Hepatology. 2011 Jun;53(6):1819-29. doi: 10.1002/hep.24285. Epub 2011 May 14.
6
Permissiveness of human hepatocellular carcinoma cell lines for hepatitis C virus entry and replication.
Virus Res. 2017 Aug 15;240:35-46. doi: 10.1016/j.virusres.2017.07.018. Epub 2017 Jul 24.
7
[In vitro infection of human liver cancer cell line HepG2 with HCV].
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2003 Mar;17(1):77-80.
8
[PreC/C gene-targeting RNA interference suppresses hepatitis B virus replication and expression in human hepatoma cells].
Zhonghua Yi Xue Za Zhi. 2012 Mar 20;92(11):768-72.
9
New insights into hepatitis B and C virus co-infection.
J Hepatol. 2009 Sep;51(3):423-5. doi: 10.1016/j.jhep.2009.06.003. Epub 2009 Jun 23.
10
Mouse hepatic cells support assembly of infectious hepatitis C virus particles.
Gastroenterology. 2011 Sep;141(3):1057-66. doi: 10.1053/j.gastro.2011.06.010. Epub 2011 Jun 13.
引用本文的文献
1
Consensus small interfering RNA targeted to stem-loops II and III of IRES structure of 5' UTR effectively inhibits virus replication and translation of HCV sub-genotype 4a isolates from Saudi Arabia.
Saudi J Biol Sci. 2021 Jan;28(1):1109-1122. doi: 10.1016/j.sjbs.2020.11.041. Epub 2020 Nov 17.
2
A review on current status of antiviral siRNA.
Rev Med Virol. 2018 Jul;28(4):e1976. doi: 10.1002/rmv.1976. Epub 2018 Apr 15.
3
In Silico Design and Experimental Validation of siRNAs Targeting Conserved Regions of Multiple Hepatitis C Virus Genotypes.
PLoS One. 2016 Jul 21;11(7):e0159211. doi: 10.1371/journal.pone.0159211. eCollection 2016.
4
Deep Sequencing Insights in Therapeutic shRNA Processing and siRNA Target Cleavage Precision.
Mol Ther Nucleic Acids. 2014 Feb 4;3(2):e145. doi: 10.1038/mtna.2013.73.
5
Inhibition of hepatitis C virus in chimeric mice by short synthetic hairpin RNAs: sequence analysis of surviving virus shows added selective pressure of combination therapy.
J Virol. 2014 May;88(9):4647-56. doi: 10.1128/JVI.00105-14. Epub 2014 Jan 29.
6
Prospects for nucleic acid-based therapeutics against hepatitis C virus.
World J Gastroenterol. 2013 Dec 21;19(47):8949-62. doi: 10.3748/wjg.v19.i47.8949.
7
Minimal-length Synthetic shRNAs Formulated with Lipid Nanoparticles are Potent Inhibitors of Hepatitis C Virus IRES-linked Gene Expression in Mice.
Mol Ther Nucleic Acids. 2013 Sep 17;2(9):e123. doi: 10.1038/mtna.2013.50.
8
The anti-genomic (negative) strand of Hepatitis C Virus is not targetable by shRNA.
Nucleic Acids Res. 2013 Apr 1;41(6):3688-98. doi: 10.1093/nar/gkt068. Epub 2013 Feb 8.
9
Safe, long-term hepatic expression of anti-HCV shRNA in a nonhuman primate model.
Mol Ther. 2012 Sep;20(9):1737-1749. doi: 10.1038/mt.2012.119. Epub 2012 Jun 26.
10
Possibilities for RNA interference in developing hepatitis C virus therapeutics.
Viruses. 2010 Aug;2(8):1647-1665. doi: 10.3390/v2081647. Epub 2010 Aug 6.
本文引用的文献
1
Modulation of HIV-1 replication by RNA interference.
Nature. 2002 Jul 25;418(6896):435-8. doi: 10.1038/nature00896. Epub 2002 Jun 26.
2
Short interfering RNA confers intracellular antiviral immunity in human cells.
Nature. 2002 Jul 25;418(6896):430-4. doi: 10.1038/nature00873. Epub 2002 Jun 26.
3
siRNA-directed inhibition of HIV-1 infection.
Nat Med. 2002 Jul;8(7):681-6. doi: 10.1038/nm725. Epub 2002 Jun 3.
4
Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells.
Nat Biotechnol. 2002 May;20(5):500-5. doi: 10.1038/nbt0502-500.
5
RNA interference and small interfering RNAs.
Chembiochem. 2001 Apr 2;2(4):239-45. doi: 10.1002/1439-7633(20010401)2:4<239::AID-CBIC239>3.0.CO;2-R.
6
ATP requirements and small interfering RNA structure in the RNA interference pathway.
Cell. 2001 Nov 2;107(3):309-21. doi: 10.1016/s0092-8674(01)00547-5.
7
Enhancement of hepatitis C virus RNA replication by cell culture-adaptive mutations.
J Virol. 2001 May;75(10):4614-24. doi: 10.1128/JVI.75.10.4614-4624.2001.
8
Post-transcriptional gene silencing by double-stranded RNA.
Nat Rev Genet. 2001 Feb;2(2):110-9. doi: 10.1038/35052556.
9
RNA interference--2001.
Genes Dev. 2001 Mar 1;15(5):485-90. doi: 10.1101/gad.880001.
10
Role for a bidentate ribonuclease in the initiation step of RNA interference.
Nature. 2001 Jan 18;409(6818):363-6. doi: 10.1038/35053110.
Zotero 插件